dapagliflozin
astrazeneca
['heart failure', 'farxiga', 'astrazeneca']
three and a half months after teasing a topline win for its heart failure and type 2 diabetes med farxiga, astrazeneca laid out the details of the drug s performance in another heart failure patient population to a crowd at #esc22. 
The biopharma world is here. Get the industry’s most comprehensive daily news report at https://t.co/rXFyNyZcJs